Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;31(6):489-494.
doi: 10.1097/ICU.0000000000000707.

Neuro-ophthalmic manifestations of coronavirus disease 19

Alanna K Tisdale  1 , Bart K Chwalisz  2   3
Affiliations
Review

Neuro-ophthalmic manifestations of coronavirus disease 19

Alanna K Tisdale et al. Curr Opin Ophthalmol. 2020 Nov.

Abstract

Purpose of review: To provide a summary of the neuro-ophthalmic manifestations of coronavirus disease 19 (COVID-19), documented in the literature thus far.

Recent findings: A small but growing literature documents cases of new onset neuro-ophthalmic disease, in the setting of COVID-19 infection. Patients with COVID-19 have experienced acute onset vision loss, optic neuritis, cranial neuropathies, and Miller Fisher syndrome. In addition, COVID-19 increases the risk of cerebrovascular diseases that can impact the visual system.

Summary: The literature on COVID-19 continues to evolve. Although COVID-19 primarily impacts the respiratory system, there are several reports of new onset neuro-ophthalmic conditions in COVID-infected patients. When patients present with new onset neuro-ophthalmic issues, COVID-19 should be kept on the differential. Testing for COVID-19 should be considered, especially when fever or respiratory symptoms are also present. When screening general patients for COVID-19-associated symptoms, frontline physicians can consider including questions about diplopia, eye pain, pain with extraocular movements, decreased vision, gait issues, and other neurologic symptoms. The presence of these symptoms may increase the overall probability of viral infection, especially when fever or respiratory symptoms are present. More research is needed to establish a causal relationship between COVID-19 and neuro-ophthalmic disease, and better understand pathogenesis.

PubMed Disclaimer

References

    1. World Health Organization. Coronavirus disease (COVID-2019) situation reports July 2020. Situation report – 180 2020; Geneva, Switzerland: World Health Organization, Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed July 18, 2020.
    1. CDC. Coronavirus Disease 2019 (COVID-19): cases in the U.S. : United States Department of Health and Human Services (HHS) 2020 [updated July 18, 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html.
    1. Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: the reality and challenges. J Microbiol Immunol Infect 2020; 53:436–443.
    1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323:1061–1069.
    1. Lee IC, Huo TI, Huang YH. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc 2020; 83:521–523.

LinkOut - more resources